本页面由Tiger Trade Technology Pte. Ltd.提供服务

Bicara Therapeutics

16.58
+0.18001.10%
成交量:9.11万
成交额:149.68万
市值:9.08亿
市盈率:-7.44
高:16.64
开:16.49
低:16.23
收:16.40
52周最高:19.71
52周最低:7.80
股本:5,478.20万
流通股本:2,413.40万
量比:0.22
换手率:0.38%
股息:- -
股息率:- -
每股收益(TTM):-2.2271
每股收益(LYR):-4.0460
净资产收益率:-26.64%
总资产收益率:-18.59%
市净率:2.26
市盈率(LYR):-4.10

数据加载中...

2026/02/19

重要事件披露

Form 8-K - Current report
2026/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/12

重要事件披露

Form 8-K - Current report
2025/12/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/08

重要事件披露

Form 8-K - Current report
2025/11/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/10

重要事件披露

Form 8-K - Current report
2025/10/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities